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SYMPOSIUM ON PORTAL HEPATOTROPHIC FACTORS 
At the 24th annual meeting of the Amer-
ican Association for the Study of Liver 
Diseases on November 1, 1973, the Roche 
Symposium on Portal Hepatotrophic Fac-
tors was presented, The participants of this 
symposium and their presentations were as 
follows: 
Development of the Hepatotrophic Con-
cept: a Century of Controversy, Thomas E. 
Starzl (Denver, Colorado), 
The Hepatotrophic Concept from a Bio-
chemist's Point of View. Hans A. Krebs 
(Oxford. England), 
The Identification of Hepatotrophic 
Su bstances by Tissue Culture Techniques. 
Rudi Schmid and D. Montgomery Bissell 
(San Francisco. California). 
The Hepatotrophic Substance and Liver 
Regeneration. ::--.r ancy L. R. Bucher (Bos-
ton, Massachusetts). 
Clinical Ramifications with Particular 
Reference to Portacaval Shunting, Glyco-
gen Storage Disease, and Idiopathic Famil-
ial Hyperlipoproteinemia. Charles W. Put-
nam (Denver, Colrado). 
Glucagon as a Modifier of Hepatic Re-
generation in the Rat. J. B. Price, Jr., A. 
Whittemore, M. Kasuya, P. Fodor, and A. 
B. Voorhees. Jr. (New York, New York). 
Induction of Premature Structural Dif-
ferentiation of Fetal Hepatocytes by Glu-
cagon. H. F. Chiu and M. J. Phillips 
(Toronto, Canada). 
Implications in Hepatology. Hans Pop-
per (New York. New York). 
The symposium was concerned with an 
old controversy in light of new, recently 
accumulated information. The subjects 
discussed dealt with the effects of sub-
stances in portal venous blood on liver 
morphology, function, and regenerative ac-
tivity. 
Until the last few years, there was no 
agreement at all that venous blood return-
ing from the various splanchnic organs 
contributed anything specific to the wel-
fare of the liver. Convincing evidence that 
this was true was first provided by experi-
ments with auxiliary hepatic transplanta-
tion in which one of two coexisting livers 
was given splanchnic venous blood. 
whereas the other organ was revascularized 
with an equal or greater volume of portal 
inflow from nonsplanchnic sources. The 
liver cells nourished by splanchnic blood 
underwent hypertrophy, glycogen accumu-
lation. and hyperplasia relative to the liver 
cells which were denied this kind of portal 
perfusion. The same kinds of observations 
of the importance of splanchnic venous 
blood have been made in a variety of other 
experiments, including many not involving 
transplantation. 
What is the nature of these so-called 
hepatotrophic effects? Tentative answers 
have come from experiments which divided 
the splanchnic blood into two 
components-one derived from the upper 
intestinal organs (pancreas. spleen, stom-
ach. and duodenum) and the other derived 
from the rest of the small intestine and the 
colon. With this kind of splanchnic divi-
sion, the liver fragment receiving the hor-
mone-rich eff1uent from the upper abdomi-
nal organs flourished, whereas the liver 
fragment given the nutrient-rich intestinal 
blood underwent atrophy and deglycogena-
tion. Studies of cyclic adenosine mono-
phos pha te, glucokinase, phosphorylase. 
and other enzymes in the hepatic tissues 
provided further circumstantial evidence 
that an interaction of pancreatic hormones 
(particularly insulin and glucagon) was a 
crucial aspect of the hepatotrophic effect. 
Indeed. the analysis of Krebs underscored 
the naivete of ascribing the hepatotrophic 
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effects to any single hormone as opposed to 
the interrelationships of hormones and 
probably other factors as well, including 
nutrients. It was pointed out by Krebs that 
some of the essential amino acids (lysine in 
particular) may have actions which simu-
late hormones. 
One approach for working out the expla-
nation for splanchnic hepatotrophic effects 
is selective ablation of different splanchnic 
organs or hormone-producing tissues. 
Some preliminary data were presented on 
the influence of total pancreatectomy and 
alloxan diabetes on the liver tissue of ani-
mals subjected to the splanchnic division 
described above, but the complicated na-
ture of these experiments has been a seri-
ous disadvantage. Bissell's technique of 
monolayer culture of metabolically active 
liver cells could permit far more precise 
analysis of hepatotrophic factors by per-
mitting the addition or subtraction of hor-
mones or other substances from the me-
dium. Preliminary efforts of this kind of 
systematic screening were described. 
Since the emergence and increasing ac-
ceptance of the hepatotrophic hypothesis, 
secondary controversies have erupted 
about the importance of splanchnic venous 
blood in the control of regeneration. In 
partially hepatectomized animals deprived 
of portal blood, Bucher observed that hy-
perplasia is delayed and less vigorous than 
when portal blood is provided. Price 
showed, in a similar preparation, that the 
infusion of insulin and glucagon restored 
hyperplasia to normal levels. These obser-
vations support the general point of view 
that hepatotrophic substances are not cen-
tral to the initiation of regeneration, but 
that their absence may blunt the vigor of a 
regenerative response. To use Bucher's 
term, the hepatotrophic substances are 
"permissive and enhancing." Chiu re-
ported the profound effect that at least one 
hormone (glucagon) could have on the 
differentiation of fetal hepatocytes. 
Finally, some clinical notations were 
made in the context of the hepatotrophic 
hypothesis. First, successful techniques for 
auxiliary liver transplantation have been 
designed with the objective of routing 
splanchnic venous blood into the ectopic 
homograft. Second, the palliation by por-
tacaval shunt of patients with the specific 
enzyme defects of hepatic glycogenoses was 
reinterpreted in light of recent advances in 
understanding of the hepatotrophic con-
cept. Finally, in the same vein, a case of 
portal diversion for the treatment of homo-
zygous type II hyperlipidemia was de-
scribed with astonishing clinical palliation 
and with a serum cholesterol drop from 
about 1000 to 250 mg per 100 ml. The 
switch-off of cholesterol and lipoprotein 
metabolism in this important case illus-
trated again the profound physiological 
consequences of bypassing hepatotrophic 
substances around their usual first order 
hepatic capillary bed. 
It was obvious from the Symposium 
discussions that the hepatotrophic hypoth-
esis has opened an inviting new field for 
investigation in hepatology. The far-reach-
ing implications of the concept were the 
subject of the exciting review by Dr. Hans 
Popper of New York, which concluded the 
Roche Symposium and which has been 
preserved in its entirety in the following 
pages. 
